Prescription Weight Loss Cost Comparison Explained
Understanding Wegovy vs Mounjaro Prescription Weight Loss Pricing
When examining why Wegovy appears cheaper than Mounjaro for prescription weight loss, several factors contribute to the pricing structure. Wegovy (semaglutide) operates as a single GLP-1 receptor agonist, whilst Mounjaro (tirzepatide) functions as a dual GIP and GLP-1 receptor agonist with newer manufacturing processes. The established production scale for semaglutide, combined with Novo Nordisk's longer market presence, often translates to more competitive pricing for patients seeking prescription weight loss solutions.
Both treatments require identical clinical oversight as prescription-only medicines, yet the cost difference between Wegovy and Mounjaro often reflects manufacturing maturity rather than clinical superiority. At EverydayMeds (GPhC #9012878), we provide transparent pricing for both options, allowing patients and prescribers to make informed decisions based on clinical suitability and budget considerations rather than marketing claims.
Wegovy Pricing Structure and Value for Weight Management
Our Wegovy pricing reflects the true cost of prescription weight loss treatment, starting with the 0.25mg dose at £79.99 for weeks 1-4 of your journey. The dose escalation continues with 0.5mg at £94.99, 1mg at £99.99, 1.7mg at £139.99, and the maintenance 2.4mg dose at £209.99. New customers can apply discount code FIRST40 at checkout, whilst returning patients use DOSE25, with these prices representing your final cost after discount application.
When comparing why Wegovy costs less than Mounjaro, our bundle options provide additional convenience without hidden charges. The Intro Duo (0.25mg & 0.5mg) costs £169.99, covering your first 8 weeks, whilst the Ultimate Stability Trio provides three months of 2.4mg maintenance supply for £649.99. These bundles offer supply security and reduced ordering frequency rather than per-pen savings, addressing practical concerns about prescription weight loss continuity.
Clinical Evidence Supporting Wegovy's Prescription Weight Loss Efficacy
The STEP clinical trial programme demonstrates why Wegovy represents effective prescription weight loss treatment regardless of its cost comparison to Mounjaro. In STEP 1, patients taking Wegovy alongside diet and exercise achieved approximately 15% average weight loss at 68 weeks compared to 2.4% with placebo (Wilding et al., NEJM, 2021). STEP 2 showed 9.6% weight reduction in patients with type 2 diabetes, whilst STEP 3 demonstrated clinically studied weight loss with intensive behavioural therapy.
These results explain why Wegovy's pricing remains competitive with Mounjaro - the clinical efficacy is well-established through extensive trials. The SELECT cardiovascular outcomes study further showed a 20% reduction in major cardiovascular events, adding value beyond weight management. Both treatments require prescription-only medicine status and clinical monitoring, but Wegovy's established evidence base supports its position in the prescription weight loss market.
How Wegovy Works for Prescription Weight Loss
Wegovy functions as a GLP-1 receptor agonist, mimicking your body's natural fullness hormone to support appetite regulation and weight management. The once-weekly injectable treatment works on brain appetite centres, potentially reducing food cravings and promoting satiety after smaller meals. This mechanism explains why Wegovy can be cost-effective compared to Mounjaro - it targets the same primary pathway with proven results. The FlexTouch pen delivery system provides consistent dosing throughout your prescription weight loss journey. Combined with a reduced-calorie diet and increased physical activity, Wegovy supports sustainable weight management through physiological appetite control rather than temporary restrictions.
Streamlined Ordering Process for Wegovy Prescription Weight Loss
Starting your Wegovy prescription weight loss journey takes just three minutes with our online clinical assessment at EverydayMeds. Our prescribers review your medical history, current medications, and weight management goals to determine suitability for treatment. Standard review takes three working days, with express 24-hour options available for urgent requirements. Once approved, your prescription-only medicine is dispatched via next-day cold-chain delivery, maintaining the 2-8°C temperature requirements. This efficient process demonstrates why Wegovy pricing includes comprehensive clinical support, prescription review, and temperature-controlled logistics - representing genuine value in prescription weight loss care.
Storage Advantages and Practical Considerations
Wegovy offers practical advantages that contribute to its cost-effectiveness compared to Mounjaro, particularly regarding storage flexibility. Whilst both require refrigeration at 2-8°C before first use, Wegovy maintains stability for 6 weeks at room temperature below 30°C once removed from the fridge. Mounjaro's 21-day room temperature limit makes Wegovy more suitable for travel, work schedules, or temporary storage challenges. The dose escalation protocol progresses systematically: 0.25mg (weeks 1-4), 0.5mg (weeks 5-8), 1mg (weeks 9-12), 1.7mg (weeks 13-16), and 2.4mg maintenance from week 17 onwards. This structured approach ensures optimal tolerance whilst achieving prescription weight loss goals with minimal side effects.
Cost-Effectiveness Analysis: Wegovy vs Mounjaro for Long-Term Weight Management
When evaluating why Wegovy appears cheaper than Mounjaro for prescription weight loss, consider the total cost of ownership beyond initial pricing. Wegovy's longer room temperature stability reduces wastage from storage mishaps, potentially saving replacement costs. The established supply chain and manufacturing scale often provide more consistent availability compared to newer treatments like Mounjaro.
Both medications require identical clinical monitoring and lifestyle modification support, but Wegovy's pricing structure allows for better budget planning throughout your weight management journey. At EverydayMeds (GPhC #9012878), we stock both treatments, enabling your prescriber to recommend the most clinically appropriate and financially suitable option based on your individual circumstances rather than limiting choices due to cost concerns.
Making Your Prescription Weight Loss Investment Decision
Your prescription weight loss treatment represents an investment in long-term health outcomes, making cost comparison between Wegovy and Mounjaro just one decision factor. Apply discount code FIRST40 for new customers or DOSE25 for returning patients at checkout to access our competitive Wegovy pricing. Our clinical team provides ongoing support throughout your treatment journey, ensuring optimal results from your prescription-only medicine investment. Visit https://everydaymeds.co.uk/collections/wegovy to complete your clinical assessment and start your weight management journey with transparent pricing, expert clinical support, and temperature-controlled delivery. Both Wegovy and Mounjaro are available from EverydayMeds - your prescriber can help determine which treatment offers the best value for your specific weight loss goals and medical profile.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
